Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate Medical Device Investing
ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial Life Science Investing
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement Life Science Investing
